Vickers A - Search Results

1

Can we deliver randomized trials of focal therapy in prostate cancer?

Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M; Prostate Cancer RCT Consensus Group. Ahmed HU, et al. Among authors: vickers a. Nat Rev Clin Oncol. 2014 Aug;11(8):482-91. doi: 10.1038/nrclinonc.2014.44. Epub 2014 Apr 22. Nat Rev Clin Oncol. 2014. PMID: 24751803 Review.

2

Statistical reanalysis of four recent randomized trials of acupuncture for pain using analysis of covariance.

Vickers AJ. Vickers AJ. Clin J Pain. 2004 Sep-Oct;20(5):319-23. doi: 10.1097/00002508-200409000-00006. Clin J Pain. 2004. PMID: 15322438 Clinical Trial.

3

Unconventional anticancer agents: a systematic review of clinical trials.

Vickers AJ, Kuo J, Cassileth BR. Vickers AJ, et al. J Clin Oncol. 2006 Jan 1;24(1):136-40. doi: 10.1200/JCO.2005.03.8406. J Clin Oncol. 2006. PMID: 16382123 Free PMC article. Review.

4

Interpreting data from randomized trials: the Scandinavian prostatectomy study illustrates two common errors.

Vickers A. Vickers A. Nat Clin Pract Urol. 2005 Sep;2(9):404-5. doi: 10.1038/ncpuro0294. Nat Clin Pract Urol. 2005. PMID: 16474658 No abstract available.

5

The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.

Masterson TA, Bianco FJ Jr, Vickers AJ, DiBlasio CJ, Fearn PA, Rabbani F, Eastham JA, Scardino PT. Masterson TA, et al. Among authors: vickers aj. J Urol. 2006 Apr;175(4):1320-4; discussion 1324-5. doi: 10.1016/S0022-5347(05)00685-3. J Urol. 2006. PMID: 16515989 Free PMC article.

6

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.

Steuber T, Vickers AJ, Serio AM, Vaisanen V, Haese A, Pettersson K, Eastham JA, Scardino PT, Huland H, Lilja H. Steuber T, et al. Among authors: vickers aj. Clin Chem. 2007 Feb;53(2):233-40. doi: 10.1373/clinchem.2006.074963. Epub 2006 Dec 21. Clin Chem. 2007. PMID: 17185368

7

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

Lilja H, Ulmert D, Vickers AJ. Lilja H, et al. Nat Rev Cancer. 2008 Apr;8(4):268-78. doi: 10.1038/nrc2351. Nat Rev Cancer. 2008. PMID: 18337732 Review.

8

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.

Vickers AJ, Savage C, O'Brien MF, Lilja H. Vickers AJ, et al. J Clin Oncol. 2009 Jan 20;27(3):398-403. doi: 10.1200/JCO.2008.18.1685. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064972 Free PMC article. Review.

9

The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost.

Vickers AJ, Scardino PT. Vickers AJ, et al. Trials. 2009 Mar 5;10:14. doi: 10.1186/1745-6215-10-14. Trials. 2009. PMID: 19265515 Free PMC article.

10

Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.

O'Brien MF, Cronin AM, Fearn PA, Smith B, Stasi J, Guillonneau B, Scardino PT, Eastham JA, Vickers AJ, Lilja H. O'Brien MF, et al. Among authors: vickers aj. J Clin Oncol. 2009 Aug 1;27(22):3591-7. doi: 10.1200/JCO.2008.19.9794. Epub 2009 Jun 8. J Clin Oncol. 2009. PMID: 19506163 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

982 results

Search Page